Tags: Drug.

PankoMab is a humanized monoclonal antibody recognizing the tumor-specific epitope of mucin-1 (TA-MUC1) enabling it to differentiate between tumor MUC1 and non-tumor MUC1 epitopes. PankoMab is being developed by Glycotope GMBH and is currently undergoing a phase II clinical trial for ovarian cancer

ATC prefix
none

Loading...

This page contains content from the copyrighted Wikipedia article "Pankomab"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.